DOVA stock forecast
Our latest prediction for Dova Pharmaceuticals, Inc.'s stock price was made on the Oct. 1, 2019 when the stock price was at 27.87$.
In the short term (2weeks), DOVA's stock price should underperform the market by -0.98%. During that period the price should oscillate between -12.36% and +14.92%.
In the medium term (3months), DOVA's stock price should underperform the market by -0.44%. During that period the price should oscillate between -22.97% and +31.66%.Get email alerts
Create a solid portfolio with DOVA
About Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.
At the moment the company generates 13M USD in revenues.
On its last earning announcement, the company reported a loss of -2.56$ per share.
The book value per share is 3.89$
Three months stock forecastOct. 1, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|